$13.34
+0.14 (+1.06%)
Open$13.29
Previous Close$13.20
Day High$13.74
Day Low$12.98
52W High$19.11
52W Low$5.30
Volume—
Avg Volume872.7K
Market Cap1.14B
P/E Ratio—
EPS$-3.16
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
-31.0% upside
Current
$13.34
$13.34
Target
$9.21
$9.21
$6.71
$9.21 avg
$14.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 36.75M | 40.31M | 211.34M |
| Net Income | -271,719,595 | -268,232,571 | 52.60M |
| Profit Margin | -739.4% | -702.5% | 24.9% |
| EBITDA | -282,453,836 | -294,319,561 | 60.54M |
| Free Cash Flow | — | — | 38.74M |
| Rev Growth | -8.8% | -8.8% | -6.2% |
| Debt/Equity | — | — | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |